XML 71 R60.htm IDEA: XBRL DOCUMENT v3.19.3
Fair Value of Financial Instruments (Details-4) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]        
Beginning balance, $ (33,337,000) $ (37,332,000) $ (32,002,000) $ (42,026,000)
Realized and unrealized gains (losses):        
Included in regulatory assets 4,317,000 2,018,000 2,982,000 6,711,000
Included in other comprehensive income 0 0 0 0
Included in earnings [1] (492,000) 26,000 (1,928,000) (434,000)
Included in current assets 4,000 (25,000) (198,000) (496,000)
Purchases 5,205,000 5,736,000 16,827,000 17,602,000
Sales 0 0 0 0
Issuances 0 0 0 0
Settlements (4,717,000) (5,737,000) (14,701,000) (16,671,000)
Transfers in and/or out of level 3 0 0 0 0
Ending balance, $ (29,020,000) $ (35,314,000) $ (29,020,000) $ (35,314,000)
[1] MGE's exchange-traded derivative contracts, over-the-counter party transactions, purchased power agreement, and FTRs are subject to regulatory deferral. These derivatives are therefore marked to fair value and are offset in the financial statements with a corresponding regulatory asset or liability.